Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7494 USD | -32.49% | -30.61% | -46.47% |
08/05 | Transcript : Seres Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Seres Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.47% | 168M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Oppenheimer Adjusts Seres Therapeutics Price Target to $10 From $12, Maintains Outperform Rating